A Study in Healthy Men to Find the Best Formulation of BI 894416 and to Test How This is Taken up in the Body
Status:
Terminated
Trial end date:
2020-11-30
Target enrollment:
Participant gender:
Summary
The main objective of this trial is to select a formulation principle (tablet vs. capsule)
and to optimize the identified extended release formulation of BI 894416, if needed.